ADMA Biologics Inc Receivables 2013-2024 | ADMA
- ADMA Biologics Inc receivables for 2023 were $0.027B, a 76.85% increase from 2022.
- ADMA Biologics Inc receivables for 2022 were $0.016B, a 45.74% decline from 2021.
- ADMA Biologics Inc receivables for 2021 were $0.029B, a 115.89% increase from 2020.